AssiVWarwickJCuzickJ,et al.Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol2012; 9: 33–40.
2.
GilbertFJPayneNRAllajbeuI, et al.Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial. Lancet2025; 405: 1935–1944.
BakkerMFde LangeSVPijnappelRM, et al.Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med2019; 381: 2091–2102.
5.
OhuchiNSuzukiASobueT, et al.Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan strategic anti-cancer randomized trial (J-START): a randomised controlled trial. Lancet2016; 387: 341–348.
6.
PötschNVatteroniGClauserP, et al.Contrast-enhanced mammography versus contrast-enhanced breast MRI: a systematic review and meta-analysis. Radiology2022; 305: 94–103.
7.
PayneNRHickmanSEBlackR, et al.Breast density effect on the sensitivity of digital screening mammography in a UK cohort. Eur Radiol2025; 35: 177–187.
8.
BennettRLSellarsSJMossSM. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer2011; 104: 571–577.
9.
ChaltielDHillC. Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?BMJ Open2021; 11: e046353.
